Determination of Circadian Rhythms in Consumer-Grade Actigraphy Devices by Yeutter, Gregory William
Determination of Circadian Rhythms
in Consumer-Grade Actigraphy Devices
A Thesis





in partial fulfillment of the







Gregory W. Yeutter. All Rights Reserved.
ii
Dedications
To my parents, Susan, Ken, Debbie, and Marc, who sparked a passion for art, science, and
industry.
To my brother, Tom, for helping me push the boundaries of what is possible.
To my grandparents, Mary Ann and Bill, whom I don’t call nearly enough.
To Dr. McEachron, for always pushing me to try harder.
To Dr. Abichandani, for your incredible patience.
To Dr. Ellis, for insisting that I do the right thing.
To Yitian, for being there when things were tough.
To Max, for constantly inspiring my creativity.
To Nick, for helping me question my assumptions.
To Stevie, who might not be around much longer. Hang in there.
iii
Acknowledgements
My time at Drexel has been eye-opening. Life has taken so many unexpected turns, and despite
some lows among the highs, I can truly say it has always worked out for the best.
Reflecting, the experience has been profound. I completed both a bachelor’s and master’s degree
in electrical engineering. I took classes in a number of subjects outside the typical engineering
curriculum. I served as a leader in several organizations. I had the chance to work at two companies
that couldn’t be more different. I learned to express myself in a different language. I lived, studied,
and worked in two foreign cities for a whole year, and got to see some of the world’s great places.
I worked in a lab that helped me understand how my passion, light, can benefit people. And I
founded a company to translate the ideas gained there and elsewhere into reality. Along the way, I
encountered countless individuals who serve to inspire and challenge.
If I could sum up my education in one word, it would be opportunity. Drexel gives you a template
and a bunch of breathing room, then challenges you to make the most of it. The opportunities are
all there. You just have to have enough persistence and grit to seize them. Were there things I
would have done differently? Sure. But I think I turned out alright regardless.
Numerous times I’ve bent the rules and taken the less-traveled route. Mistakes were made, but
much was gained, especially in the form of character. I expect, however, that there is still much to
learn in this area and others.
I want to apologize to those I’ve inconvenienced and caused to go outside their job descriptions.
I hope you’ll forgive me. But I also want to thank you all for helping me learn more about myself.
As I write this, I’m coming out of a trough. Not fully back, but almost there. It’s been all of
you who are reading this, and many that are not, who have whipped me into shape and supported
me when I really needed it. I’m grateful for the experience, even if you wouldn’t call it desirable.
And I’ve learned that no matter what, I still have myself.
With this thesis, I hope that I can contribute, in some small way, to the advancement of art,
science, and industry. Those three words were part of the original title of this institution, and they
remain on a triangle in the center of the university emblem to this day.
The triangle is the strongest shape, but without any of the sides, it is drastically weakened. This
should serve as a reminder that without any one of the three, you hardly have any of the other. The
future is going to be made by individuals who are simultaneously scientists and captains of industry.
But most importantly, these forward-thinkers must view their work as art.
iv
Table of Contents
List of Abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vi
List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
List of Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . viii
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 Problem Statement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.1 The Circadian Rhythm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.2 Actigraphy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.1.3 Accessible Circadian Determination Through Actigraphy . . . . . . . . . . . 3
1.2 Contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.3 Organization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
2 Relevant Background and Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . 6
2.1 Biological Rhythms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
2.1.1 Biological Clocks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
2.1.2 The Circadian Rhythm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2.1.3 Chronodisruption . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.2 Sleep . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.2.1 The Importance of Sleep . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.2.2 The Five Stages of Sleep . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.3 Actigraphy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.3.1 The Actigraphy Landscape . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.3.2 Quantifying the Circadian Rhythm Through Actigraphy . . . . . . . . . . . . 16
2.3.3 Literature Review: Comparing Actigraphy to Polysomnography . . . . . . . . 17
2.3.4 Literature Review: Comparing Consumer to Clinical Actigraphy Devices . . . 18
v2.4 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.4.1 Intelligent Environments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.4.2 Smart Drug Delivery Systems . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.4.3 Individualized Health Recommendations . . . . . . . . . . . . . . . . . . . . . 20
3 Experiment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
3.1 Experimental Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
3.1.1 Applied Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
3.1.2 Justification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
3.1.3 Concepts for Further Experimentation . . . . . . . . . . . . . . . . . . . . . . 24
3.2 Overview of Metrics and Statistical Techniques . . . . . . . . . . . . . . . . . . . . . 25
3.2.1 Statistical Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
3.2.2 Platform Metrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
3.2.3 Time-Series Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
3.3 Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3.3.1 Bed Time and Wake Up Time . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3.3.2 Time Awake and Asleep . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.3.3 Number of Awakenings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
3.3.4 Wake After Sleep Onset . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
3.3.5 Sleep Efficiency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.3.6 Sleep Onset Latency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.3.7 Time-Series Activity Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.4 Summary of Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
4.1 Quantitative Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
4.2 Subjective Interpretation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
4.3 Actigraphy in the Real World . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
List of References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
Appendices . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
vi
List of Abbreviations
ACT Actigraphy. 2, 3, 5, 15–20, 23, 24, 51, 53, 54
API Application Programming Interface. 16, 17, 23, 24, 26
ECG/EKG Electrocardiography. 3, 14
EEG Electroencephalography. 3, 14
EMG Electromyography. 3, 14
EOG Electrooculography. 3, 14
HR Heart Rate. 14, 17, 23
ipRGCs Intrinsically Photosensitive Retinal Ganglion Cells. 2, 8, 10–12
IRB Institutional Review Board. 24
LED Light-Emitting Diode. 19
PSG Polysomnography. 2, 3, 14, 15, 17, 18, 53
REM Rapid Eye Movement. 13–15
SCN Suprachiasmatic Nucleus. 2, 9, 11
SE Sleep Efficiency. vii, 3, 16–20, 25–27, 35, 49–51
SOL Sleep Onset Latency. 16–18, 26, 27, 35, 49–51
TST Total Sleep Time. vii, 3, 16–20, 26, 27, 30–32, 48–51, 53
WASO Wake After Sleep Onset. vii, 3, 16–18, 26, 27, 34, 35, 48–51
vii
List of Tables
3.1 Definitions of Sleep Metrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
3.2 Summary of Collected Data Points . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
3.3 Bed Time Comparison . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3.4 Wake Up Time Comparison . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.5 Time Spent in Bed Comparison . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.6 Time Spent Asleep Comparison . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3.7 Time Spent Awake Comparison . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3.8 Total Sleep Time (TST) Comparison . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.9 Percent of Time Asleep Comparison . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.10 Percent of Time Awake Comparison . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
3.11 Number of Awakenings Comparison . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
3.12 Wake After Sleep Onset (WASO) Comparison . . . . . . . . . . . . . . . . . . . . . . 34
3.13 Sleep Efficiency (SE) Comparison . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.14 Sleep Onset Latency Comparison . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
4.1 Results of Metric Comparisons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
viii
List of Figures
1.1 Example of an Actogram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
2.1 Phase Shift Representation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
3.1 Equipment Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
3.2 Bed Time and Wake Up Time Comparison . . . . . . . . . . . . . . . . . . . . . . . 38
3.3 August 5-6 Time Series Amplitude Data . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.4 August 7-9 Time Series Amplitude Data . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.5 August 10-11 Time Series Amplitude Data . . . . . . . . . . . . . . . . . . . . . . . . 41
3.6 August 12-13 Time Series Amplitude Data . . . . . . . . . . . . . . . . . . . . . . . . 42
3.7 August 14-15 Time Series Amplitude Data . . . . . . . . . . . . . . . . . . . . . . . . 43
3.8 August 16-17 Time Series Amplitude Data . . . . . . . . . . . . . . . . . . . . . . . . 44
3.9 Distribution of Fitbit Intensity Values for All Nights . . . . . . . . . . . . . . . . . . 45
3.10 Distribution of Scaled Actiwatch Intensity Values for All Nights . . . . . . . . . . . . 45
3.11 Correlation Coefficients of All Metrics . . . . . . . . . . . . . . . . . . . . . . . . . . 46
ix
Abstract
Determination of Circadian Rhythms




The recent growth in popularity of fitness-tracking watches is a major step in the right direction
for individual health awareness. It turns out that these devices are very similar electronically to
clinical-grade devices used to study sleep health. Those clinical devices are not available for sale
to the general public, and cost in the range of $1,500-$2,000. If the output of the consumer fit-
ness tracker compares well with the medical-grade device, individuals may soon be able to deeply
understand and optimize their sleep.
This experiment consisted of a test subject simultaneously wearing two clinical Respironincs
Actiwatch 2 devices and a consumer device, the Fitbit Charge HR (suggested retail price $149.95
U.S.). The experiment was performed over twelve nights. The data output for each platform was
compared following the conclusion of the study.
The results demonstrate that the Fitbit Charge HR corresponds well with the Respironics Acti-
watch 2 in terms of five sleep time metrics: bed time, wake up time, time spent in bed, time spent
asleep, and total sleep time. Other measures do not correspond well or have statistically significant
differences between the platforms. These include time spent awake in bed, number of awakenings,
sleep efficiency, sleep onset latency, percent of time asleep, and percent of time awake. Time-series
data and the wake after sleep onset metric have fair correspondence between the platforms, and the
data may be used with knowledge of the limitations.
This experiment shows that a consumer-grade fitness-tracking device may provide some depend-
able data points for individuals looking to understand their sleep hygiene. Based on these results,
three case studies for health-aware systems are presented: adaptive environments, drug delivery
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In this chapter, the problem statement is provided with some high-level information about the
relevant concepts. Specific contributions of this work are highlighted, followed by the organization
of the rest of this thesis.
1.1 Problem Statement
The problem statement is outlined in three parts. First, an overview of the circadian rhythm is
presented in Section 1.1.1. Then, actigraphy is briefly described in Section 1.1.2. Finally, the
primary motivation for this thesis is presented in Section 1.1.3.
1.1.1 The Circadian Rhythm
Circadian rhythms are any endogenous (i.e. self-generating) rhythms which have a period of ap-
proximately 24 hours and can be synchronized by external environmental cycles. The human body
contains multiple circadian clocks responsible for a variety of functions. These rhythms serve to
consolidate sleep and wakefulness in humans to a relatively consistent daily pattern [1]. In addition,
the body displays circadian rhythmicity in virtually every variable biochemical, physiological, and
behavioral parameter. These include body temperature regulation, memory processing, immunity,
and cell repair processes, among many others [2–4].
Although the circadian rhythms will drive themselves indefinitely, they may come out of syn-
chronization with daily geophysical cycles if not exposed to them in the proper manner [5]. It turns
out that light, whether natural or artificial, influences the human circadian rhythm [6]. For millenia,
humans were exposed to the most light in the middle of the day, with near total darkness at night.
Between the peak and trough of the day, there was a gradual rise of total environmental light in
2the morning followed by a fall toward darkness in the evening. The advent of artificial lighting
has brought about numerous advantages to society, but humans now live largely indoors with light
inputs at all hours of the day [7].
Specific neurons in the human eye, known as intrinsically photosensitive Retinal Ganglion Cells
(ipRGCs), are sensitive to blue light, with an absorption spectrum which peaks around 480 nm.
These photoreceptive neurons communicate with the suprachiasmatic nucleus (SCN) along the
retinohypothalamic tract. The SCN is the home of cells that constitute a biological clock, known
as the circadian rhythm. The SCN has connections with numerous other regions of the brain. One
prominent connection is the pineal gland, which modulates body temperature and produces the
hormone melatonin [6, 8–10].
Circadian rhythms that are out of synchronization with the natural environment can lead to
numerous short-term and long-term health consequences. In the short term, these may include
fatigue, insomnia, lack of focus, and reduced memory function. In the long term, chronic circadian
disruption may contribute to accelerated aging and degenerative diseases [7, 11].
1.1.2 Actigraphy
Actigraphy (ACT) involves the use of an accelerometer (a type of motion sensor) to measure gross
motor activity. The most common application of ACT in clinical settings is monitoring and analyzing
sleep behavior. Although traditional polysomnography (PSG) has been considered for decades to be
the ‘gold standard’ for sleep assessment, and may be necessary to definitively diagnose most sleep
disorders, the setup is inconvenient and expensive, limiting applications in the real world. ACT
presents a legitimate alternative to PSG, allowing unlimited mobility and sleep in the subject’s
natural sleep environment [12].
ACT has been used for over thirty years to answer certain clinical and research questions. Par-
ticularly, an unobtrusive form and relatively low cost enable objective data collection in large popu-
lations where the issue of burden is important, as well as in cases where chronic behaviors must be
represented reliably. Since ACT is often used for more nights than the one or two typical of PSG,
more representative data may be obtained [12, 13].
The ACT device used in sleep studies is typically found in a wristwatch-like form factor, and is
meant to be worn on the wrist for a week or more. It generally consists of a piezoelectric accelerom-
eter, a band-pass filter that eliminates noise outside of the band between approximately 0.25 Hz and
3 Hz, on-board memory, and a data interface [14]. The data interface may be physical connection,
3used to manually transfer data to a computer, or a wireless connection, which synchronizes with a
nearby device periodically.
While PSG can output time-series data for multiple body functions including heart rhythm
(ECG/EKG), eye movement (EOG), brain wave activity (EEG), and muscle activation (EMG)
[15, 16], ACT is a one-dimensional measure of wrist movement [12]. Despite this limitation, clinical
ACT devices provide highly-detailed sleep metrics, and are shown to reflect individuals’ sleep-wake
cycles with reasonable validity and reliability. These metrics may include TST, SE, WASO, circadian
rhythm information, and information about daytime activity or inactivity [12]. Typical values are
highly correlated with PSG (refer to Section 2.3.3) [14, 16–19].
PSG and ACT devices are typically paired with software that provides some level of automated
data analysis. Examples of metrics are time in bed, total sleep time (TST), sleep efficiency (SE -
the amount of time spent asleep relative to time in bed), and number of awakenings. In addition,
these tools may output visual polysomnograms or actograms. See Figure 1.1 and Appendix 5 for
actograms generated by Actiwatch 2 in this experiment.
In the past few years, multiple wearable fitness-tracking products have been released, most often
in the form of an unobtrusive wristwatch-like device. These fitness trackers promise to quantify
or estimate number of steps walked, heart rate, calories burned, and time spent asleep, among
other metrics. It turns out these fitness trackers are very similar electronically to medical-grade
ACT devices, and may even be manufactured by the same company. These devices are available to
the general public at prices ranging from $15 to $300, a fraction of the cost of their clinical ACT
counterparts [20].
1.1.3 Accessible Circadian Determination Through Actigraphy
If ACT devices can capture detailed, reasonably accurate information about sleep and circadian
rhythms, can their much cheaper counterparts do the same? In this thesis, the data output from a
consumer-grade fitness tracking device is compared to the data from a clinical-grade ACT device.
Multiple metrics from each platform are analyzed, with the goal of distinguishing circadian rhythm
information from the output data on the more-accessible device. Although various regulations may
prevent diagnosis based on the output of the fitness tracker, numerous other possibilities in the realm
4Figure 1.1: Example of an Actogram. This actogram was generated from the Philips Respironics
Actiwear software for a Respironics Actiwatch 2 device. This actogram also displays information
about red and white light exposure.
of personalized medicine may soon be realized.
1.2 Contributions
In this thesis, the following work was completed:
1. Evaluation of the metrics provided by each actigraphy platform and determination of which
metrics can be directly compared.
2. Normalization and transformation of data that cannot be directly compared in an attempt
to enhance the correlation of output between both platforms.
53. Determination of which metrics are reliably comparable, and assessment of the validity of
each platform for determination of circadian rhythmicity and sleep-related biomarkers.
1.3 Organization
The remainder of this thesis is organized as follows:
• In Chapter 2, the relevant background regarding biological rhythms, sleep, and actigraphy
(ACT) is introduced. In addition, the motivation for the use of affordable ACT devices to
measure circadian rhythms is presented.
• In Chapter 3, the experimental procedure is outlined, and the methods are described in
detail. The data output from the ACT device and fitness tracker are compared, plotted, and
analyzed.
• In Chapter 4, the results from Chapter 3 are discussed. These results are then put into the
context of technologies that are being developed in the area of personalized medicine.
• Finally, in Chapter 5, the work is further summarized. Future directions for related research
are presented.
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In this chapter, the relevant background for this thesis is presented. Section 2.1 covers biological
rhythms, biological clocks, the human circadian rhythm, and the impacts of chronodisruption on
the circadian rhythm. Section 2.2 reviews the importance of sleep in the short and long term,
and goes into detail about the five stages of sleep. Section 2.3 presents an overview of actigraphy
and demonstrates how the circadian rhythm may be distinguished from time-series and quantitative
data. Section 2.4 puts this experiment in perspective and discusses some possibilities for derivative
works.
2.1 Biological Rhythms
Complex, goal-driven devices have the fundamental need to organize and create order for the various
activities in which they engage [15]. Whether or not these systems are living, the need for internal
temporal order imposes a requirement for some sort of timing mechanism to organize internal events
7for maximum efficiency. A fundamental property of nearly any system is its ability to maintain order
over time, typically by using or resulting in rhythmicity. Examples vary widely: there are daily and
monthly tidal cycles, the seasons, the timing of automobile pistons, clocks in modern microprocessors,
and the human heartbeat. Even within a single system, multiple levels of rhythmicity are present.
A healthy human will exhibit breathing cycles, a sequence of repetitive muscle movements when
walking, a daily pattern of wake and rest, and in the case of females, menstrual cycles, among other
rhythms [15].
Reliable systems – those that continue to operate over years or decades – are successful in part
because they are able to exist in their environments in relative temporal equilibrium. An instructive
example is the “on-time bird.” It is possible that the common cliché, the early bird gets the worm,
may be in part misleading. Since worms only appear at the surface at a specific time of day, it would
be advantageous for a bird to collect its share of a limited selection of worms before the other birds.
However, this bird might also be eaten or attacked by predators if it shows up too early, waiting
around for worms to appear. In addition, the bird must carry out other activities, such as mating,
building a nest, and protecting its offspring, so it makes sense that there is a specific, limited time
for feeding when worms are available and predators are at a minimum [15].
The primary reasons for evolution supporting rhythmicity are [15]:
1. The requirement for timing in any complex system
2. The tendency of feedback systems to oscillate
3. Internal and environmental constraints that lead to oscillations and generate selection pres-
sures:
(a) The rhythmic nature of internal processes, including breathing and cardiac cycles
(b) Geophysical cycles based on earth’s path around the sun
Biological rhythms are essential and critical components of all living systems. Because so many
systems in the environment exhibit oscillations, these cycles are almost impossible to avoid. The
organism must adapt to its environment to increase its chance of success, and survival is maximized
if the organism exhibits oscillations itself [15].
82.1.1 Biological Clocks
Biological rhythms vary in frequency from multiple cycles per second (e.g. neural oscillations) to
multi-year periods of oscillation at the ecosystem level. But how does one stay synchronized with
the surrounding world? It is the responsibility of autorhythmic oscillators known as biological clocks
to regulate and adapt to the wide variety of rhythms.
In the study of biological rhythms, known as chronobiology, the process of synchonization to
environmental cycles is known as entrainment. An environmental cycle that can entrain a biological
rhythm is known as a Zeitgeber, literally "time-giver" in German. A biological clock may also be
referred to as a pacemaker.
In order for a biological clock to entrain to a Zeitgeber and extend oscillations to auxiliary functions,
the following components are required [5, 15]:
• The Zeitgeber
• A method of perceiving the Zeitgeber
• A method of coupling perception to the pacemaker (Z to P coupling)
• A pacemaker with an inherent frequency close to that of the Zeitgeber
• Amethod by which the pacemaker controls behavioral and physiological processes (P to Output
coupling)
• The physiological and behavioral processes
Species exhibit enormous variation in terms of their methods for perceiving, maintaining, and out-
putting biological rhythms. For example, on earth, the most obvious Zeitgeber is the daily cycle of
light and dark, which may also change with season depending on latitude. Mammals are believed to
have specialized photoreceptors in the retina, known as intrinsically photosensitive retinal ganglion
cells (ipRGCs), which detect this cycle and serve as an input to pacemakers, while other vertebrates
may have additional extra-retinal photoreceptors. Other cycles may serve as Zeitgebers in some
species, including feeding and exercise cycles and environmental temperature rhythms [15].
Entrainment to Zeitgebers can alter both the phase and frequency response of a pacemaker’s
characteristic rhythm. Biological clocks have both an endogenous (internal, self-driving) and an
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nous components, some internal rhythms may entrain more easily to the external environment than
others [5].
Through a tool known as the phase response curve, chronobiologists can analyze the influence
of an external factor on an internal rhythm. There are three primary periods that affect the phase
response that link endogenous and exogenous components. The first is the period of the Zeitgeber,
often signified by T . The second is the underlying period of the internal rhythm, known as τ .
The third period is the observed period of the biological clock, which incorporates the underlying
endogenous rhythm with the phase changes affected by the Zeitgeber. This is signified by τ* [5].
The phase angle between the exogenous and endogenous cycles is governed by the ratio T/τ .
If this ratio grows larger, the internal rhythm will display a phase advance, or left shift. If the
ratio shrinks, the entrained rhythm will exhibit a phase delay, or right shift [5]. These effects are
portrayed in Figure 2.1. Note that the figure is an abstract representation of the concept. Units are
excluded in this example.
Although the pacemaker exhibits a single characteristic frequency that is entrained to the Zeitge-
ber, it can control an internal cascade of multiple rhythms with different frequencies. A distinction is
thus made between a master pacemaker and many secondary oscillators. The process of entrainment
between the master and secondary rhythms is yet another Zeitgeber-pacemaker relationship, with
the master pacemaker maintaining the cycle that the secondary rhythm entrains to [21].
2.1.2 The Circadian Rhythm
In humans and many other animals, it turns out that the the circadian (about a day) rhythm is the
fundamental rhythm around which other activities are organized. There is a master pacemaker, the
SCN, that is synchronized by the external light/dark cycles which repeat daily. Numerous secondary
oscillators are entrained by the SCN. Although there are other geophysical cycles with periods of
about 24 hours, such as the change of temperature and humidity from day to night, it is unclear if
these cycles influence the SCN [15].
If placed in a constant environment, such as one where it is either dark all the time or light all
the time, the human circadian rhythm tends to “free-run,” with a period slightly longer than than
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Figure 2.1: Phase Shift Representation. The original response is displayed in black. A phase advance,
or left shift, is displayed in red. A phase delay, or right shift, is displayed in blue.
24 hours. This means that the clock contains an endogenous component that regulates itself in the
absence of external stimuli, and has a period somewhere in the vicinity of 24 hours. However, we
know that humans tend to exhibit behaviors on a period that is almost exactly 24 hours, such as
waking up and becoming hungry at around the same time every day. So, this exogenous component
must somehow be adjusted to match the environmental cycles to which the individual is exposed
[15, 22].
Because the clock tends to free-run in constant light or darkness, it can be hypothesized that light
is a factor that helps synchronize, or entrain, the endogenous rhythm to the external environment.
The most prevalent and understood photoreceptors are rods and cones. Rods are responsible for
mostly monochromatic vision in low light. Cones are triggered in brighter light and are responsible
for humans’ perception of color [23, 24].
It turns out that a third set of cells within the human eye, known as intrinsically photosensitive
retinal ganglion cells (ipRGCs), inform the circadian rhythm when there is light and when it is
absent. Although not traditionally considered to be photoreceptors (not contributing to visual
image formation), ipRGCs respond to blue-shifted light wavelengths even when rods and cones are
not excited. ipRGCs represent less than 3% of retinal ganglion cells, but they are sufficient to relay
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information about ambient light intensity to the the part of the brain responsible for maintaining
the circadian rhythm [6, 23, 24].
The retinal ganglion cells of some mammals appear to contain a pigment known as melanopsin.
While the rods and cones are part of the mechanism that track visual objects and patterns, the
melanopsin-containing ipRGCs encode the general environmental illumination level. In turn, the
response of ipRGCs controls the size of pupils, informs the circadian rhythm of light and dark, and
leads to acute suppression of locomotor behavior [24].
In most mammals, the master pacemaker or clock regulating circadian rhythms is located within
the suprachiasmatic nucleus (SCN). The SCN is a small region within the hypothalamus directly
above the optic chiasm. Information is relayed from the ipRGCs to the SCN via the retinohypotha-
lamic tract [10, 15].
The human body has numerous circadian clocks which are synchronized to the master pacemaker
in the SCN. A prominent example of one of these clocks is the pineal gland, which secretes hormones
such as melatonin and contributes to the regulation of body temperature. The SCN also signals the
pituitary gland to secrete growth hormone and factors related to blood pressure, thyroid, metabolism,
sex organs, and nursing, among others, although melatonin may reinforce these processes [10, 15].
It may start to become obvious that the circadian rhythm is not only responsible for feelings of
wakefulness and tiredness by alternating the release of cortisol and melatonin, but that it also con-
tributes to many of the body’s vital processes, including reproductive cycles and repair mechanisms.
Even when cycles are themselves variable, such as heartbeat and breathing rates depending on ac-
tivity level, there are still mechanisms linking the circadian pacemaker and these other frequencies.
In the long term, small but chronic disruptions in repair processes may even accelerate the processes
associated with aging and contribute to degenerative disorders such as dementia, osteoporosis, and
cancer [7, 10, 11].
2.1.3 Chronodisruption
The rotation and revolution of the earth around the sun has remained quite consistent for nearly 4
billion years. Over that long period of time, organisms’ sensory systems adapted to detect geophys-
ical cycles by indirect means, such as sensing the changes in light and temperature in the immediate
environment. The links between changes in light and temperature and the geophysical cycle are
indirect, so signals about light and temperature may be inappropriately timed to the actual geo-
physical situation. The discovery of fire and invention of artificial light sources illustrate this point:
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light and heat can be controlled at the will of humans. Thus, in many circumstances, the presence
or absense of light and heat do not reflect the true geophysical situation.
In today’s always-connected society, disruption of biological rhythms, or chronodisruption, is
alarmingly common. Electric lighting, which can output the blue light wavelengths to which the
ipRGCs are sensitive, can trick the body into thinking it is daytime, even in the middle of the
night. Televisions, PCs, smartphones, and other electronics with bright displays exaggerate this
effect. People spend less time outdoors than ever before, with less exposure to sunlight during the
day than past generations. Even when outside, nighttime light pollution and daytime smog may
interfere with circadian entrainment. It is possible to travel halfway across the world to a completely
different photoperiod in a number of hours. Students and workers sacrifice sleep or pull all-nighters
to succeed in a chronically high-pressure environment. These are just several of many examples, but
one can conclude that chronic circadian disruption is not an edge case, but more common than not
[7, 15, 25].
In the days following the yearly shift from standard time to daylight savings time, motor vehicle
accident and acute myocardial infarction (heart attack) rates increase [26, 27]. In epidemiological
studies on humans, individuals who routinely work at night or have disrupted circadian rhythms
for other reasons have higher reported incidence of breast, prostate, endometrial, and colorectal
cancer. When animals in experimental studies are continually phase advanced or exposed to light
at night, cancer growth is exaggerated [7]. In 2007, the International Agency for Research on
Cancer (IARC) declared shift work involving chronodisruption to be carcinogenic to humans. This
includes "unavoidable" or "critical" shift work, such as in medical scenarios. Although causal data
for the actual mechanical processes that link chronodisruption to cancer are only in the early stages
of understanding, it is known that the hormone melatonin is a key biological intermediary and
biomarker for the overall circadian state. In other words, not enough time has elapsed to establish a
causal link between chronodisruption and cancer, but the sampling of biomarkers such as melatonin
may provide insights into temporal hygiene and serve as predictors for the presence of degenerative
disease later in life [25].
2.2 Sleep
In this section, the importance of sleep is highlighted, followed by more specific information about
each of the distinct stages of sleep.
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2.2.1 The Importance of Sleep
From an evolutionary perspective, sleeping does not initially appear to be adaptive. A sleeping
organism lies relatively unprotected for hours with a reduced responsiveness to external stimuli,
making it an easy target for predators. In addition, sleeping organisms cannot obtain food or other
resources, cannot mate, cannot defend their offspring, and cannot perform a whole host of other
clearly adaptive activities [28, 29].
If the organism has evolved to remain in such a state for a significant portion of the day, the
processes that occur during sleep must be vital for survival. This can be tested by examining the
results of total or near total sleep deprivation. For example, rats under total sleep deprivation
exhibited skin lesions, loss of temperature regulation, and weight loss despite increased eating after
several days, and death between days 11 and 32 [30]. In addition, loss of any of the individual
phases of sleep results in a disproportionate gain in those same phases when uninhibited sleep is
again possible. In other words, if the duration of REM sleep is shorter one night, it will be longer
on subsequent nights if sleep quality and duration are uninhibited [28, 29].
Sleep is theorized to be important for a number of specific reasons, both physiological and behav-
ioral. One is the need to conserve energy in resource-constrained environments. A complementary
reason is that the organism may be maladapted to the environment during certain parts of the 24-
hour cycle. For example, diurnal (day-active) organisms, including humans, tend to have relatively
poor vision at night. If such a diurnal species cannot effectively navigate its environment for half
of the photoperiod, it it also less likely to spot predators during this time. As a result, it is safer
to remain in place, exhibiting fewer observable movements that signal to nocturnal (night-active)
predators that prey are nearby. By limiting movement, the sleeping organism also metabolizes less
energy [15, 28, 29].
By reducing sensory input, the brain can use this extra processing power to prioritize, organize,
store, and recall information. It can also eliminate new information that is not important for survival.
Because less energy is devoted to muscular movements, regeneration and repair of cells throughout
the body can occur. Combined, all of these processes may be too resource-intensive to occur to the
full extent during active or even restful wake [28, 29].
Numerous factors can interfere with sleep, including unfamiliar surroundings, light and other
stimuli, dietary choices, social pressures, and stress. Interference with sleep has numerous short-
term effects, including insufficient cell repair, increased energy consumption, and ineffective memory
processing and recall. These effects may build up over time and can contribute to degenerative
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disorders, lack of immune function, cardiovascular disease, metabolic syndrome, obesity, and an
inability to recall learned information [11, 28, 29].
Incomplete sleep and chronodisruption are correlated, and it is hypothesized that chronic sleep
deprivation is linked with increased occurrence of cancers later in life. By extension, sleep deprivation
early in life may contribute to increased disease risk, despite decades of separation [7, 11].
2.2.2 The Five Stages of Sleep
Sleep scientists commonly characterize sleep into three broad categories: transitional or light sleep,
slow-wave or deep sleep, and paradoxical or active sleep. These broad categories are further divided
to form four or five distinct stages. The five-stage version will be described here using a diagnos-
tic technique known as polysomnography (PSG), which combines measurements of eye movement
(EOG), heart rate (HR - via ECG/EKG), muscle activity (EMG), and electrical changes in the brain
(EEG) [16, 28].
Stages 1 and 2 both fit into the category of transitional or light sleep. During stage 1, EEG
recordings shift toward a lower frequency of 3-7 Hz, the eyes begin to roll slowly, and muscle activity
is low or moderate. Stage 2 is similar, although “K complexes” (brief high/low-voltage spikes) and
“sleep spindles” (12-14 Hz waves occurring for at least 0.5 seconds) appear on the EEG reading
amidst low-frequency background oscillations. These structures appear to be involved in memory
consolidation and sleep preservation [28, 31].
In the category of deep or slow wave sleep are stages 3 and 4. While ocular and muscle activity
is unchanged from stages 1 and 2, high-amplitude, low-frequency (0.5-2 Hz) “delta” waves start to
appear in EEG measurements in stage 3. Stage 4 is the same, except that EEG activity shows more
than 50% delta waves [28].
Stage REM (rapid-eye movement) is also known as paradoxical or active sleep. The most distinct
variation in this stage is the appearance of rapid eye movement (REM) bursts in EOG readings.
Muscle activity patterns are low, but with occasional twitches. EEG readings show alpha (7.5-12.5
Hz) and beta waves (12.5-30 Hz), hence the names paradoxical and active reflecting this high level
of brain activity. [28].
The five stages transition toward each other in a zigzag-like pattern throughout a typical, healthy
night. Starting from wake, the body follows the pattern 1-2-3-4. After stage 4, it transitions to 3
then 2, but then proceeds to stage REM. After REM, the pattern repeats: 2-3-4-3-2-REM. Following
this second bout of REM, stages 2, 3, and REM may repeat, and later only stage 2 and REM may
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repeat. Near the end of sleep, the body will transition from REM to stage 1 to wake [28].
2.3 Actigraphy
Actigraphy is the application of simple motion-tracking sensors to capture information about the
human body. Current uses for actigraphy are described in Section 2.3.1. In Section 2.3.2, the
concept of tracking circadian rhythm information via actigraphy is proposed. Sections 2.3.3 and
2.3.4 contain literature reviews of relevant actigraphy work done to date.
2.3.1 The Actigraphy Landscape
The state of the circadian rhythm can be measured using several relatively-common diagnostic tests,
some more invasive than others. In the relatively invasive category, there are blood concentration
samples of hormones like melatonin and cortisol, as well as polysomnography (PSG). Slightly less
invasive are salivary tests for hormone concentration. All of these techniques require either active
intervention multiple times per day or restrict free movement in a way that can impede normal
activity [16].
An alternative to these invasive tests is actigraphy (ACT), or tracking motion through a multiple-
axis accelerometer mounted in a compact wearable device, such as a wristband. Because of this form
factor, ACT devices are no more invasive than wristwatches, and their low power consumption means
they can record motion data for days or weeks before the small onboard batteries need replacement
or recharging.
The validity of ACT has been confirmed for evidence-based sleep analysis in clinical settings.
The technique provides acceptably accurate sleep pattern estimation in healthy adult populations
as well as infants, children, and older adults. It is indicated for individuals suspected of certain
sleep disorders [32]. Differential diagnoses may be aided by ACT in addition to sleep logs and
questionnaires. For monitoring circadian rhythms and insomnia, the results of ACT may be more
valid than PSG in some cases. PSG is not indicated routinely for evaluating chronic insomnia, while
the unobtrusiveness of ACT makes it appropriate for this application [33].
Time-series amplitude measurements for ACT devices are acceptably correlated with PSG during
sleep (see Section 2.3.3) [32], meaning that time spent in the various stages of sleep can be determined
relatively accurately from this compact device. Time spent is the various stages of quiet and active
sleep can provide a picture of one’s overall circadian health, as different sleep stages are associated
with different functions, such as memory processing and cell repair [14, 16, 18]. When PSG is not
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available, ACT can be substituted to estimate total sleep time (TST).
Until recently, ACT devices were limited to clinical and research settings, with primary use in
sleep studies. While clinically-approved ACT devices produce consistent results and have very long
battery life (about a month), they are prohibitively expensive (on the order of $1,000 to $2,000
U.S.) and can only be analyzed using expensive, proprietary computer applications designed for
sleep scientists intimately familiar with chronobiology. In addition, these devices mostly only record
data on internal memory, so near-live feedback about circadian states due to changes in habit or
environment is not currently possible.
Within the past several years, however, ACT devices have entered the mainstream in the form of
wearable fitness trackers. Aimed at consumers looking to be more active, these devices can quantify
or estimate number of steps walked, calories burned, time asleep, and in newer models, live heart rate
using optical sensors. Some models will provide information about time spent in active and quiet
sleep, but with little actionable insight and questionable application of proper scientific terminology.
While the output from these devices are not approved for clinical use or cross-checked between
manufacturers, studies show reasonably well-correlated findings from common sensors, with similar
drawbacks or inaccuracies between the various commercial and consumer devices [13, 34]. These
devices are much more affordable (typically $30-$250), synchronize with a smartphone wirelessly
several times per day, and have some data available in the form of web application programming
interfaces (APIs). In addition, technology from consumer fitness trackers is being integrated directly
in smartwatches from multiple popular brands [20, 34]. Despite the fact that clinical trials have not
been performed with these devices, they may soon enable live tracking of circadian health in a much
more accessible package.
2.3.2 Quantifying the Circadian Rhythm Through Actigraphy
Actiware, the PC software compatible with the medical-grade Actiwatch 2 used in this experiment,
is a powerful tool for automated ACT data analysis. It outputs actograms detailing time-series
activity and light levels, as displayed in Figure 1.1 and Appendix 5. In addition, Actiware provides
numerous relevant data points, including bed time, wake up time, time spent in bed, total sleep time
(TST), sleep onset latency (SOL), time awake after sleep onset (WASO), number of awakenings, sleep
efficiency (SE - the number of minutes asleep relative to the total time in bed), percentage of sleep
and wake, and exposure to white and red light. Time-series data is provided for binary sleep vs.
wake (i.e. 0 when the subject is asleep, 1 during wake), activity amplitude (a continuous range),
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and white light exposure [35].
Fitbit, the manufacturer of the Charge HR consumer device used in this experiment, provides
a web API [20, 36] for accessing the data from their devices. The API provides access to relevant
data including resting heart rate (if available), number of awakenings, WASO, TST, minutes to fall
asleep, SE, number of times restless, time spent in bed, and wake time. In addition, time-series data
is provided for activity (only low/medium/high activity) and heart rate (if available) [20, 36].
Upon initial review, it is apparent that some parameters are directly comparable between the
two ACT platforms. These include SE, TST, bed time, time spent in bed, and wake time. Some
data points may be comparable through normalization and/or transformation, such as time-series
activity. It is possible to extract data points like WASO and SOL based on time-series data with
some degree of validity. Some data points, such as light exposure and heart rate (HR), are not
comparable between the two platforms simply because the data was not available from one of the
platforms. It is impossible to compare data from a light sensor or HR sensor to that of a motion
sensor.
2.3.3 Literature Review: Comparing Actigraphy to Polysomnography
Multiple studies have explored the accuracy and clinical utility of actigraphy (ACT) in comparison
with polysomnography (PSG). In a study assessing sleep in 34 elderly insomniacs, the sensitivity, or
ability of ACT to detect sleep when a participant was sleeping according to PSG, was very high at
95.2%. However, ACT performed poorly in detecting wake, with a specificity, or ability to identify
wake when a participant was awake according to PSG, of 36.3%. The overall level of accuracy was
found to match PSG-registered sleep efficiency (SE) at 83.1%. ACT overestimated total sleep time
(TST) and SE, and consequently underestimated wake after sleep onset (WASO) and sleep onset
latency (SOL) [37].
Another study evaluated ACT, PSG, and sleep diaries in 54 patients with insomnia and depres-
sion. Sleep diaries typically include information about bed and wake times, as well as a subjective
analysis of sleep quality recorded either by the subject or a caregiver. They are typically formatted
as a questionnaire. The experiment showed moderate positive correlations between ACT and PSG
for all variables, except that ACT underestimated SOL compared to PSG. Correlation was 0.31
for SOL, 0.44 for latency to persistent sleep, 0.48 for SE, 0.59 for WASO, and 0.54 for TST. ACT
approximated PSG more closely than sleep diaries [38].
An additional study compared total number of awakenings, TST, and SE between ACT and
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PSG in 100 patients with sleep disorders. Mean accuracy for TST was 0.73, while it was 0.80 for
SE. When a high-threshold actigraphic algorithm was applied, the number of awakenings was not
significantly different between the two technologies [16].
Finally, a study compared a ACT-based and two noncontact radio-frequency biomotion sensors
to PSG in 20 normal subjects. All three devices had the tendency to underestimate SOL and
WASO while overestimating overall sleep, although TST was reasonable. All three devices showed
similar performance in comparison to PSG for all metrics and sleep/wake determination, although
the noncontact sensors had slightly improved estimates of WASO, TST, and SOL [39].
2.3.4 Literature Review: Comparing Consumer to Clinical Actigraphy
Devices
As consumer-grade fitness trackers have gained popularity, some reviews and studies have appeared
comparing them to more traditional ACT devices. A 2012 review compared six consumer sleep-
tracking products, including four accelerometer-based devices intended to be worn on the wrist
(Fitbit Flex, Jawbone UP, Basis Band, and Innovative Sleep Solutions SleepTracker). The review
found that intradevice and overall accuracy varied, and this could be partially explained by the
omission of the manufacturers to disclose their methods and algorithms in detail [34].
In a 2011 study comparing simultaneous use of a Fitbit (original model) and a medical-grade
Actiwatch-64 in 24 healthy adults, the two products differed significantly on total sleep time (TST)
and sleep efficiency (SE). Intradevice reliability between Fitbits was high, but all ACT devices tended
to overestimate TST and SE compared to PSG. Sensitivity (the ability of the device to identify the
same sleep epochs as PSG) within all sleep stages and during arousals was high for both Fitbit and
the Actiwatch, while specificity (ability of the device to identify PSG-scored wake) of both products
was low. Specificity of the Actiwatch was higher than Fitbit on all metrics except wake before sleep
onset. Fitbit had higher sensitivity in all sleep stages and during arousals [13].
Additional resources are scare. However, with these insights, expectations for the performance
of consumer-grade ACT devices can be generated based on similarities in components and form to
clinical counterparts. It should be noted that before 2014, Fitbit devices did not have the ability to
detect sleep automatically, but this changed with a software update [20]. It can be assumed that
some metrics have improved by 2016, but ACT technology does appear to have specific inherent
strengths and weak points that have not likely changed in such a short time period. In addition,
since most tracker companies have not focused their efforts on sleep, sleep insights will likely need
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to be generated manually from disparate pieces of information.
2.4 Motivation
In a world where actigraphy (ACT) devices are increasingly ubiquitous, cheap, and connected, it is
not difficult to imagine numerous scenarios in which these products may be useful beyond tracking
cardiovascular activity. Three specific possibilities include:
1. Intelligent environments that adapt to individuals’ presence and needs
2. Smart drug delivery systems that optimize dose and timing based on circadian bioavailability
3. Individual recommendations and nudges for optimizing exercise, food consumption, and rest
Each of these three items is introduced in more detail in the following sections. Throughout the
thesis, these points will be put in context of the larger experiment.
2.4.1 Intelligent Environments
Item 1 is the possibility of intelligent environments that adapt to individuals’ presence and needs.
Lighting and HVAC (heating, ventilation, and air conditioning, also known as climate control)
systems are commonly controlled by centralized automation controllers in commercial buildings,
and increasingly so in the home. Examples include internet-connected learning thermostats and
LED (light-emitting diode) light bulbs with integrated radios.
The lighting system could provide bright white light during the day and dimmer amber or orange
light (which has significantly less blue content than white light) in the evenings, entraining (synchro-
nizing) the circadian rhythm to a simulated day/night light/dark cycle. The HVAC system could
adjust its output to ensure that the person is comfortable as core temperature changes throughout
the day.
The actual period and phase of the lighting and HVAC systems’ responses would depend on the
individual’s circadian output and requirements, and would be monitored by the mechanism proposed
in this thesis. The intelligent environments could attempt to normalize a person’s circadian rhythm
after an inconsistent event is observed. Shift workers and international travelers may be able to
experience an “alternate day” with such a system.
One way this type of system could work is by analyzing sleep time indicators, such as bed time,
wake up time, and total sleep time (TST), as well as quality indicators, such as sleep efficiency (SE),
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to estimate how long and how well an individual slept in a given night. If SE was relatively low or
TST was short, the lighting may be brighter and/or whiter in the morning to promote alertness.
The following evening, the lights may dim down early to encourage sleep. Temperature adjustments
could correspond.
2.4.2 Smart Drug Delivery Systems
Item 2 is the possibility of circadian-timed drug delivery systems that can adapt dose and/or timing
to individuals’ circadian output. It is known that bioavailability for many drugs follows a circadian
rhythm. An example is a melatonin supplement, which may be naturally derived or synthesized.
Oral melatonin may be very effective at certain times of the day and completely inappropriate at
other times [40, 41].
Currently, most medications are administered according to a predefined schedule, in which the
user must take the drug at specific times every day. While these administration times are based
on generalized temporal bioavailability for a population, an individual’s peak bioavailability for a
particular drug may be different from the general recommendation, and predictable by software that
communicates with the ACT device. The device could notify the user at the optimal drug admin-
istration time. Not only can the individual take the drug at peak bioavailability, but the medical
practitioner may also be able to reduce the dose of the medication due to the high bioavailability.
In turn, side effects from the drug could be minimized [40, 41].
In addition, if a population taking a specific medication also uses the type of device presented
in this experiment, it may turn out the the generalized recommendation from clinical trials may
be slightly off once more individuals utilize the drug. This type of globalized, anonymized data
collection may help doctors and medical companies create better recommendations for their clients.
2.4.3 Individualized Health Recommendations
Item 3 is the possibility of recommendations and nudges for various health-related activities. Soft-
ware may be able to determine the best times of day for exercise, eating (and which foods are most
appropriate), and resting. It is known that heart attacks peak during the morning hours, for exam-
ple, so individuals at risk for cardiac events could be warned if their exercise intensity level exceeds
a certain threshold at that time [27]. Using learning algorithms, the software could learn about the
individual’s food intake habits and circadian responses to those habits. Over time, the profile would
improve for the individual and globally, along with recommendations.
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Naturally, regulation may prohibit some of these possibilities from general release today. How-
ever, as technology generally precedes regulation, once administrative bodies are aware of the utility
of these systems, they may alter policy to allow them.
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In Section 3.1, the experimental procedure is explained and justified based on the motivation for
this project. An overview of statistical and data analysis methods is provided in Section 3.2,
followed by presentation and analysis of the experimental data in Section 3.3.
3.1 Experimental Procedure
The experimental procedure that was applied in this thesis is explained in Section 3.1.1 and
justified in Section 3.1.2. Based on the results of this thesis, ideas for derivative works at scale are
presented in Section 3.1.3.
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Figure 3.1: Equipment Overview. The test subject wore multiple ACT devices for the experiment.
From left to right, they include two Respironics Actiwatch 2, one Fitbit Charge HR, and one Misfit
Flash (not used).
3.1.1 Applied Procedure
The test subject simultaneously wore four actigraphy (ACT) devices on the non-dominant (left)
wrist for a two-week period, between August 5 and August 18, 2015. The test setup is shown in
Figure 3.1. Two of the devices were identical Respironics Actiwatch 2 activity monitors, typically
used in clinical sleep studies. Although these devices are not available for purchase by the general
public, their approximate cost is $1500 US. The other devices were the Fitbit Charge HR (∼$150)
and the Misfit Flash (∼$30). The devices were worn all the time, only to be removed during bathing
and, in the case of the Fitbit Charge HR, during charging. The Respironics and Misfit products’
batteries lasted longer than the test period, so these devices did not require charging.
At the conclusion of the experiment, the resulting data was obtained for each device. Both Fitbit
and Misfit provided a web API (application programming interface), from which relevant data was
extracted and downloaded. The Respironics devices were physically connected to a computer with
the appropriate software, Philips Respironics Actiware, from which the data for each watch was




A single test subject was chosen to minimize the administrative overhead of an Institutional Review
Board (IRB), given the timeframe, constraints, and expectations of this project. Larger experiments
would require deeper analysis by such a body to ensure safety for all participants, as well as scientific
validity in the results. This work is presented as a proof-of-concept for derivative works.
All ACT devices were worn at the same time so that the results were directly comparable. Addi-
tionally, all trackers were worn on the same wrist to maximize inter-device precision, if any existed.
The non-dominant wrist was chosen because the clinical-grade devices are only recommended to be
worn on the non-dominant side. While clinical studies have found no significant difference in noctur-
nal activity in wearing ACT devices on either wrist, the dominant wrist is general more active than
the non-dominant, and most ACT data processing algorithms are optimized for the non-dominant
side [42]. Although the consumer-grade devices had the option of being worn on either side based
on a software menu item, for the reasons outlined already, no test was performed with the trackers
on the dominant hand. A derivative work may consider comparing results between trackers worn on
both wrists.
Due to cost considerations, only one of each consumer-grade device was chosen. A derivative
experiment would include multiple of the same brand and model consumer-grade tracker to compare
inter-device reliability. Two clinical-grade ACT devices were on hand, and some of the batch had
experienced data recording issues in the past. Thus, two of the clinical-grade devices were used, and
inter-device results were compared.
The Respironics Actiwatch 2 was chosen because it was available through the university and
because it is a widely-used device in sleep studies. In addition, the associated software (Philips
Respironics Actiware) was licensed by the university. The Fitbit Charge HR was chosen because it
represented the latest full-featured offering from that company at the time, and because Fitbit is is
one of the most widely-used brands in the space. In addition, numerous sleep and time-series activity
metrics were available via the web API. The Misfit Flash was chosen because of its affordability, as
well as the ability to provide sleep metrics and time-series data via the associated API.
3.1.3 Concepts for Further Experimentation
Despite limitations in the experiment as outlined, it was prudent to establish a baseline for further
experimentation. A larger experiment would include IRB approval to perform research on multiple
subjects. A period of one-to-two weeks would be sufficient to compare output among devices and
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subjects. Ideally, the experiment would last one-to-two weeks with approximately 30 subjects, both
male and female, with at least some variation in age and lifestyle. Most subjects would only wear
one watch of each type (i.e. one Actiwatch 2 and one Fitbit Charge HR) on a single wrist. Several
subjects would wear two of each device type on the same wrist to compare inter-device reliability.
Several additional subjects would wear one device of each type on both wrists (i.e. one Actiwatch
and one Fitbit on the left side, plus one Actiwatch and one Fitbit on the right side) to compare
reliability between wrists on a single subject. If multiple clinical- or consumer-grade devices were
to be compared, the same setup (most wear just one of each device on one side, some wear multiple
of each device, some wear all devices on both wrists) could be expanded to accommodate all device
types.
3.2 Overview of Metrics and Statistical Techniques
Each platform output a number of metrics, such as the time spent asleep and sleep efficiency (SE),
in addition to time-series activity data. In this section, the statistical methods and datasets are
described in detail.
3.2.1 Statistical Methods
Multiple values are provided to understand the relationship between similar metrics on each platform.
Canonical correlation, or the extent to which two datasets are linear with one another, is represented
by ρ. The mean (x¯), median (xˆ), minimum (xmin), maximum (xmax), and standard deviation (σ)
of values are also given.
Two other tests were utilized to understand the equality of metrics provided by each device
type. The first is the Kruskal-Wallis one-way analysis of variance, and is signified by p (KW). The
second test is the Kolmogorov-Smirnov test of equality in one-way continuous distributions, which
is represented by p (KS). A significant (p < 0.05) Kruskal-Wallis ANOVA or Kolmogorov-Smirnov
result means the data are not likely generated from the same distribution. Note that the results of
the Kruskal-Wallis and Kolmogorov-Smirnov tests are only provided for comparisons between two
different device brands, and not between devices of the same brand.
3.2.2 Platform Metrics
Each platform output a series of metrics for each night. All metrics are defined in Table 3.1. The
data points available and calculated for each platform are summarized in Table 3.2.
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For the Respironics devices, metrics directly available from the associated software included bed
time, wake up time, time spent in bed, time spent asleep, total sleep time (TST), time spent awake
in bed, wake after sleep onset (WASO), sleep onset latency (SOL), number of awakenings, sleep
efficiency (SE), percent of time asleep, and percent of time awake.
Data points from the Fitbit API were bed time, time spent in bed, time spent asleep, time spent
awake in bed, number of awakenings, and SE. Other Fitbit values, including SOL, WASO, TST,
percent of time asleep, and percent of time awake were generated based on the provided data points.
Some additional calculations were made in an attempt to more closely match the Fitbit data with
the Respironics data.
Whenever average Actiwatch 2 data (A) is compared to average data from the Fitbit Charge HR
(F ) , the difference is expressed as (F −A). Whenever the Respironics devices are compared to each
other, the difference is expressed as (A1 − A2), where A1 is the first watch average value and A2 is
the second.
Mean is given as x¯, median as xˆ, standard deviation as σ, minimum as xmin, and maximum as
xmax. Correlation calculations are performed on all data points in each dataset, and the correlation
coefficient is given as ρ. The statistical significance is expressed as p. m is used as an abbreviation
for minute.
Upon initial analysis of the data, it was possible to compare all nights in the test period with
the exception of the night beginning August 8. This was due to a completely discharged battery on
the Fitbit.
3.2.3 Time-Series Data
In addition to the specific markers displayed in Table 3.2, each device output a time-series average
activity amplitude on a per-minute basis. The Actiwatch 2 data was output in two formats: a binary
sleep/wake (0/1) value, and an amplitude from 0 to 1000 (integers). The former simply tagged each
awake minute as 1 and each asleep minute as 0. In the latter case, the amplitude for each minute
was expressed on the 0 to 1000 scale.
For the Fitbit Charge HR, the only data format available was a low/medium/high binned activity
level, classified by the numbers 1, 2, and 3. During sleep episodes, 1 was classified as “sleep”, 2 as
“restless”, and 3 as “active”. These classifications may not be scientifically accurate representations
of quiet, restless, and active sleep properties, but the amplitude values are useful in this experiment.
Because of the different classification schemes by both device manufacturers, and the significantly
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Table 3.1: Definitions of Sleep Metrics
Term Definition
Bed time The time (e.g. 11:30 PM) an individual began a sleep
episode.
Wake up time The time an individual ended a sleep episode.
Time spent in bed The total time an individual was in bed (awake or
sleeping).
Time spent asleep The total time an individual was asleep.
Time spent awake The total time an individual was awake.
Total sleep time (TST) The total time of all REM and non-REM sleep in a
sleep episode.
Number of awakenings A tally of awakenings during a sleep episode.
Wake after sleep onset (WASO) The total time awake after a sleep episode has begun.
Sleep onset latency (SOL) The time it takes to transition from wakefulness to sleep
in the beginning of a sleep episode.
Sleep efficiency (SE) The ratio of sleep to the total length of the sleep episode.
% of time asleep The ratio of time spent asleep over time in bed.
% of time awake The ratio of time awake over time in bed.
Table 3.2: Summary of Collected Data Points
Marker Unit Respironics Fitbit
Bed time - D D
Wake up time - D C
Time spent in bed minutes D D
Time spent asleep minutes D D
Time spent awake minutes D D
Total sleep time (TST) minutes D C
Number of awakenings - D D,C
Wake after sleep onset (WASO) minutes D C
Sleep onset latency (SOL) minutes D C
Sleep efficiency (SE) % D D,C
% of time asleep % D C
% of time awake % D C
D: Data points collected from device output
C: Calculated or observed based on other metrics
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lower resolution of the Fitbit time-series output, the Respironics 0-1,000 amplitude integer was
binned to match the Fitbit 1, 2, and 3 dataset. A simulation was run to find a lower and upper
threshold for the "2" bin, with the goal of maximizing matches and minimizing mismatches for "2".
All Actiwatch time points with amplitude greater than 49 and lower than 391 was put into the 2
bin. Values of 49 or lower were placed in the 1 bin. Values of 391 or higher were placed in the 3 bin.
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3.3 Data Analysis
In this section, all comparable metrics from each platform are analyzed.
3.3.1 Bed Time and Wake Up Time
Both the Fitbit and Respironics platforms automatically identified bed times. Wake up times were
also determined automatically by the Respironics software. Wake up times for Fitbit were observed
manually by taking the last time entry in a sleep episode.
Both Respironics devices identified bed times as exactly the same 75% of the time, and with
1-5 minutes of difference the other 25% of the time. Wake up times were identical 91.7% of the
time, and in the single instance they were not identical, only a two-minute difference was noted.
Overall correlation for bed times was ρ = 1.000 among the Respironics devices. Between the average
Respironics response and the Fitbit output, there was a correspondence of ρ = 0.822 between the
values over all nights.
The Kruskal-Wallis test between each platform resulted in p (KW) = 0.644. The Kolmogorov-
Smirnov test resulted in p (KS) = 0.991. Both tests indicate that bed times may be drawn from the
same distribution.
The results of bed time comparisons are summarized in Table 3.3. A plot of the bed times
recorded by the Charge HR and Actiwatch 1 on a 24-hour clock is given in Figure 3.2a. The mean
time for each device is displayed as a line extending from the center of the clock face.
Table 3.3: Bed Time Comparison
Watches ρ x¯ (m) xˆ (m) xmin (m) xmax (m) σ (m)
A1 vs. A2 1.000 0 0 -5.0 0 1.0
Aavg vs. F 0.822 -2.5 -3.5 -16 12 -1.7
For wake up times recorded by both Actiwatches, the data corresponded with ρ = 1.000. For
observed Fitbit values, the correlation with the average Respironics dataset was ρ = 0.977. The
Fitbit estimates wake up time as 3 minutes before the Actiwatches, on average.
The Kruskal-Wallis test between each platform resulted in p (KW) = 0.817. The Kolmogorov-
Smirnov test resulted in p (KS) = 0.991. Both tests indicate that wake up times may be drawn from
the same distribution.
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The results of wake up time comparisons are summarized in Table 3.4. A plot of the wake up
times recorded by each device is given in Figure 3.2b.
Table 3.4: Wake Up Time Comparison
Watches ρ x¯ (m) xˆ (m) xmin (m) xmax (m) σ (m)
A1 vs. A2 1.000 0 0 -5.0 0 1.0
Aavg vs. F 0.977 -3.0 -9 -17 33 -4.7
3.3.2 Time Awake and Asleep
Six metrics are compared in this section: time spent in bed, time spent asleep, time spent awake (in
bed), total sleep time (TST), percent of time awake, and percent of time asleep. The latter three
are only reported by the Respironics software but can still be compared to the Fitbit metrics from
calculations based on the definitions of these metrics.
Time spent in bed comparisons are summarized in Table 3.5. Correspondence was ρ = 1.000
between the Respironics watches and ρ = 0.983 when comparing both platforms. The Fitbit only
underestimated time spent in bed by 1.4 minutes, on average, although there was a relatively high
standard deviation of 16.4 minutes.
The Kruskal-Wallis test between each platform resulted in p (KW) = 0.908. The Kolmogorov-
Smirnov test resulted in p (KS) = 0.991. Both tests indicate that time spent in bed results may be
drawn from the same distribution.
Table 3.5: Time Spent in Bed Comparison
Watches ρ x¯ (m) xˆ (m) xmin (m) xmax (m) σ (m)
A1 vs. A2 1.000 0.8 0.0 0 5 1.5
Aavg vs. F 0.983 -1.4 -1.8 -29 34 16.4
Time spent asleep comparisons are shown in Table 3.6. Correlation was ρ = 0.996 between the
Respironics watches and ρ = 0.975 when comparing both watch types. Fitbit overestimated time
asleep by 17 minutes, on average.
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The Kruskal-Wallis test between each platform resulted in p (KW) = 0.488. The Kolmogorov-
Smirnov test resulted in p (KS) = 0.786. Both tests indicate that time spent asleep results may be
drawn from the same distribution.
Table 3.6: Time Spent Asleep Comparison
Watches ρ x¯ (m) xˆ (m) xmin (m) xmax (m) σ (m)
A1 vs. A2 0.996 3.3 2.0 -8 14 6.4
Aavg vs. F 0.975 17.0 17.8 -12 49 17.2
Table 3.7 shows comparisons of time spent awake in bed. Correlation was ρ = 0.950 with
no statistical significance between the Actiwatch 2 devices. When comparing both products, a
correspondence of ρ = 0.710 was found. Fitbit underestimated time awake by an average of 25.9
minutes.
The Kruskal-Wallis test between each platform resulted in p (KW) = 0.002. The Kolmogorov-
Smirnov test resulted in p (KS) = 0.005. Both tests indicate that time spent awake results were not
likely drawn from the same distribution.
Table 3.7: Time Spent Awake Comparison
Watches ρ x¯ (m) xˆ (m) xmin (m) xmax (m) σ (m)
A1 vs. A2 0.950 -2.5 -2.0 -12 8 5.7
Aavg vs. F 0.710 -25.9 -24.8 -48 -12 10.9
For total sleep time (TST), results are summarized in Table 3.8. Only the Actiwatch devices
output a TST value. Comparing the Respironics watches’ TST values, a correlation of ρ = 0.996 was
found between the two devices. Comparing the Respironics average TST value to the Respironics
average time asleep value, correspondence was found to be ρ = 0.997. The time asleep value was,
on average, 6.9 minutes shorter than TST. For Fitbit, the time spent asleep (Table 3.6) value was
used. Comparing the Respironics average TST to the Fitbit time asleep, correlation was ρ = 0.977.
The Fitbit reported an average sleep time 23.9 minutes longer than the Actiwatch TST average.
The Kruskal-Wallis test between each platform resulted in p (KW) = 0.436. The Kolmogorov-
Smirnov test resulted in p (KS) = 0.786. Both tests indicate that TST results may be drawn from
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the same distribution.
Table 3.8: Total Sleep Time (TST) Comparison
Watches ρ x¯ (m) xˆ (m) xmin (m) xmax (m) σ (m)
A1 vs. A2 TST 0.996 4.3 4.5 -8 15 16.9
A TST v. A ST* 0.997 -6.9 -4.0 -20 -0.5 6.36
A TST v. F ST* 0.977 23.9 25.5 -7 52 15.7
*ST: Sleep Time
Percent of time asleep is given in Table 3.9. Since this value was only output natively from
the Respironics platform, it was obtained via two methods for Fitbit. The first method was
sleep duration
sleep duration + wake duration . The second was
sleep duration
time in bed . Correspondence between the Acti-
watches was ρ = 0.945.
Correspondence between the Actiwatch average and the first Fitbit method was ρ = 0.751. Fitbit
values were, on average, 5.23% greater than Actiwatch average values.
The Kruskal-Wallis test between each platform resulted in p (KW) = 0.001. The Kolmogorov-
Smirnov test resulted in p (KS) = 0.005. Both tests indicate that percent of time asleep results were
likely not drawn from the same distribution.
Correspondence between the Actiwatch average and the second Fitbit calculation was ρ = 0.783.
In this case, Fitbit values were only about 3.79% greater than the Actiwatch average, making this
a slightly closer comparison, despite the difference remaining significant.
The Kruskal-Wallis test between each platform resulted in p (KW) = 0.024. The Kolmogorov-
Smirnov test resulted in p (KS) = 0.066. The Kruskal-Wallis test result falls below the significance
threshold while the Kolmogorov-Smirnov result falls just above the threshold. Thus, there is only a
marginal chance these results were drawn from the same source.
Table 3.9: Percent of Time Asleep Comparison
Watches ρ x¯ (%) xˆ (%) xmin (%) xmax (%) σ (%)
A1 vs. A2 0.945 0.53 0.55 -1.47 2.34 1.15
Aavg vs. F v1 0.751 5.23 5.25 2.89 8.79 1.77
Aavg vs. F v2 0.783 3.79 3.74 1.37 8.94 2.08
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Percent of time awake is compared in Table 3.10. Since this value was only output natively
from the Respironics platform, it was obtained via two methods for Fitbit. The first method was
wake duration
sleep duration + wake duration . The second was
wake duration
time in bed . Correspondence between the Acti-
watches was ρ = 0.945.
Correspondence between the Actiwatch average and the first Fitbit method was ρ = 0.751,
although the average was about 5% lower for the consumer platform. Note that the results displayed
here are practically identical to the first Fitbit method for percent of time asleep, as this test is
essentially the inverse.
Correspondence between the Actiwatch average and the second Fitbit calculation was ρ = 0.740,
with a 5.31% lower average for Fitbit.
The Kruskal-Wallis test between each platform resulted in p (KW) = 0.001 for both calculations.
The Kolmogorov-Smirnov test resulted in p (KS) = 0.005 for both methods. These tests indicate
none of the percent of time awake results were not likely drawn from the same distribution.
Table 3.10: Percent of Time Awake Comparison
Watches ρ x¯ (%) xˆ (%) xmin (%) xmax (%) σ (%)
A1 vs. A2 0.945 -0.53 -0.55 -2.34 1.47 1.15
Aavg vs. F v1 0.751 -5.23 -5.25 -8.79 -2.89 1.77
Aavg vs. F v2 0.740 -5.31 -5.27 -8.89 -2.90 1.81
3.3.3 Number of Awakenings
Both the Actiwatch 2 and Fitbit output a value for number of awakenings, although Fitbit also
output a separate metric for number of times active. Since the Fitbit default number of awakenings
was far lower than the Actiwatch value in every instance, a separate metric for number of times
active plus number of times awake was computed for Fitbit.
Number of awakenings is compared in Table 3.10. Correspondence between the Actiwatches was
ρ = 0.977.
Correspondence between the Actiwatch average and the Fitbit native number of awakenings was
ρ = 0.747. The Kruskal-Wallis and Kolmogorov-Smirnov tests both resulted in p < 0.000, meaning
an entirely different calculation method was likely used. These results were justifiable by the number
of awakenings reported by Fitbit, which were 26 lower than the Actiwatch average per night.
34
Because the reported value was so low for this metric for Fitbit, the second calculation was
applied. Here, correspondence between the Actiwatch average and the second Fitbit calculation
was ρ = 0.715. The Kruskal-Wallis test between each platform resulted in p (KW) = 0.001. The
Kolmogorov-Smirnov test resulted in p (KS) = 0.005. Despite the average number of awaken-
ings/times active reported by Fitbit being closer to the Actiwatch avaerage (-13.5 instead of -26),
the results are still not comparable.
Table 3.11: Number of Awakenings Comparison
Watches ρ x¯ xˆ xmin xmax σ
A1 vs. A2 0.977 -1.3 -1.0 -4 3 2.3
Aavg vs. F v1 0.747 -26.0 -26.0 -36.5 -14.5 7.92
Aavg vs. F v2 0.715 -13.5 -14.0 -24.5 -0.5 6.39
3.3.4 Wake After Sleep Onset
The Actiwatch software reported a value for wake after sleep onset (WASO) in minutes, and a similar
value was calculated from the Fitbit data, based on the sum of the Awake Duration and Restless
Duration metrics. Comparing the Actiwatch devices, ρ = 0.952. Curiously, there was observable
variation on this metric between the Respironics watches, although the difference was calculated as
p = 0.330, not enough to be statistically significant. Comparing the Actiwatch average, ρ = 0.919.
The average of Respironics values was found to be 16 minutes higher than Fitbit for WASO.
The Kruskal-Wallis test between each platform resulted in p (KW) = 0.046. The Kolmogorov-
Smirnov test resulted in p (KS) = 0.186. The Kruskal-Wallis test result falls below the significance
threshold while the Kolmogorov-Smirnov result falls just above the threshold. Thus, there is only a
marginal chance these results were drawn from the same source.
Table 3.12: Wake After Sleep Onset (WASO) Comparison
Watches ρ x¯ (m) xˆ (m) xmin (m) xmax (m) σ (m)
A1 vs. A2 0.952 -2.4 -2.0 -13 8 6.0
Aavg vs. F 0.919 -16.0 -16.5 -26.5 0 7.69
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3.3.5 Sleep Efficiency
Both Fitbit and Respironics provided a sleep efficiency (SE) value, but the former estimated up to
11.4% higher and 6.5% higher on average. A second value for Fitbit sleep efficiency was computed
as tt+w , with w as WASO (in minutes) and t as time spent asleep (minutes).
Table 3.13 shows the results of this comparison. The two Actiwatch devices corresponded with
ρ = 0.943. Comparing the native Fitbit output to that of the Actiwatch, ρ = 0.778.
The Kruskal-Wallis test between each platform resulted in p (KW) = 0.001. The Kolmogorov-
Smirnov test resulted in p (KS) = 0.001. Both tests indicate that native sleep efficiency results were
not likely drawn from the same distribution.
The alternate Fitbit method resulted in ρ = 0.866 and a slightly lower average percentage. The
Kruskal-Wallis test between each platform resulted in p (KW) = 0.001. The Kolmogorov-Smirnov
test resulted in p (KS) = 0.005. Both tests indicate that calculated sleep efficiency results were also
not likely drawn from the same distribution.
Table 3.13: Sleep Efficiency (SE) Comparison
Watches ρ x¯ (%) xˆ (%) xmin (%) xmax (%) σ (%) p Sig.
A1 vs. A2 0.943 0.73 0.71 -1.47 2.54 1.29 0.232 no
Aavg vs. F v1 0.778 6.5 6.8 -3.1 11.4 2.3 3.21 e−6 exc.
Aavg vs. F v2 0.866 5.4 5.4 -2.6 8.7 2.0 3.60 e−6 exc.
3.3.6 Sleep Onset Latency
Only the Respironics software exported a value for SOL, although an attempt was made to quantify
this value for Fitbit by counting the number of minutes the Fitbit reported “2” or higher (on the
1-2-3 scale) in the beginning of a sleep episode. More time-series data analysis is given in Section
3.3.7.
Table 3.14 compares the results. Between the Actiwatches, ρ is somewhat low at 0.874 with
a difference of p = 0.440. Comparing both platforms, ρ = 0.196. The Fitbit method tends to
overestimate this value compared to the Actiwatch, but not always.
The Kruskal-Wallis test between each platform resulted in p (KW) = 0.015. The Kolmogorov-
Smirnov test resulted in p (KS) = 0.066. The low correlation and marginal Kruskal-Wallis and
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Kolmogorov-Smirnov test results indicate that these results were likely not drawn from the same
distribution.
Table 3.14: Sleep Onset Latency Comparison
Watches ρ x¯ (m) xˆ (m) xmin (m) xmax (m) σ (m) p Sig.
A1 vs. A2 0.874 0.33 0.00 0 3 0.89 0.440 no
Aavg vs. F 0.196 3.58 3.75 -6 11 5.12 6.76 e−2 mar.
3.3.7 Time-Series Activity Data
The histograms of the entire Fitbit and Actiwatch datasets are displayed in Figures 3.9 and 3.10.
Subjectively, the nearly identical distribution validates the Actiwatch scaling method described in
Section 3.2.3.
Several statistical tests were performed to determine the correspondence between the Fitbit
time-series dataset and the binned dataset for Respironics. A canonical correlation analysis found
ρ = 0.483. The results of linear regression were: R2 = 0.233, p = 3.41e−159, RMSError = 0.26.
These results indicate that the models have a marginal fit with a high degree of statistical significance.
A Kruskal-Wallis one-way ANOVA analysis was run, resulting in p (KW) = 0.158. A two-sample
Kolmogorov-Smirnov test was performed, with p (KS) = 0.999. The values can be accepted as part
of the same distribution.
The time-series data in this format are plotted for each day in Figures 3.3 to 3.8. Time points
that matched exactly (i.e. both platforms reported the same value at the same time) are plotted
in black, while values unique to Fitbit and unique to Respironics are plotted in green and red,
respectively.
It should be noted that on some plots, including Figures 3.3b, 3.4a, 3.4b, 3.6a, and 3.6b, no data
points overlap between the devices. This may be partially due to the fact that Fitbit sometimes
reports data with one-minute periods starting and ending on the half minute instead of the start
of the minute (e.g. 11:45:30 PM instead of 11:45:00 PM). The exact reason for this behavior is
unknown.
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3.4 Summary of Results
In this section, the results from Section 3.3 are presented concisely.
The time-series analysis from Section 3.3.7 is considered. With the Actiwatch data points
scaled to resemble the 1-2-3 output of Fitbit, the two platforms can be compared. The histograms
found in Figures 3.9 and 3.10 show nearly identical distributions with a similar quantity of data
points.
For all metrics, correlation coefficients between the two platforms are displayed in Figure 3.11.
















(b) Wake Up Times
Figure 3.2: Bed Time and Wake Up Time Comparison. Individual times determined by the Acti-
watch (red) and Fitbit (blue) are plotted on the unit circle. The mean bed time for each device is
represented by a line extending from the center of the circle.
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Figure 3.3: August 5-6 Time Series Amplitude Data. Fitbit (green) values are approximated from
the 1-2-3 amplitude output as 0-0.3-0.6. Actiwatch (red) values are scaled from their 0-1,000 output
values down to 0-1.0.
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Figure 3.4: August 7-9 Time Series Amplitude Data. Fitbit (green) values are approximated from
the 1-2-3 amplitude output as 0-0.3-0.6. Actiwatch (red) values are scaled from their 0-1,000 output
values down to 0-1.0.
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Figure 3.5: August 10-11 Time Series Amplitude Data. Fitbit (green) values are approximated from
the 1-2-3 amplitude output as 0-0.3-0.6. Actiwatch (red) values are scaled from their 0-1,000 output
values down to 0-1.0.
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Figure 3.6: August 12-13 Time Series Amplitude Data. Fitbit (green) values are approximated from
the 1-2-3 amplitude output as 0-0.3-0.6. Actiwatch (red) values are scaled from their 0-1,000 output
values down to 0-1.0.
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Figure 3.7: August 14-15 Time Series Amplitude Data. Fitbit (green) values are approximated from
the 1-2-3 amplitude output as 0-0.3-0.6. Actiwatch (red) values are scaled from their 0-1,000 output
values down to 0-1.0.
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Figure 3.8: August 16-17 Time Series Amplitude Data. Fitbit (green) values are approximated from
the 1-2-3 amplitude output as 0-0.3-0.6. Actiwatch (red) values are scaled from their 0-1,000 output
values down to 0-1.0.
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Figure 3.9: Distribution of Fitbit Intensity Values for All Nights
Figure 3.10: Distribution of Scaled Actiwatch Intensity Values for All Nights
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In this chapter, more detailed analysis of the data is presented in Section 4.1. Subjective impres-
sions are then given in Section 4.2. Some ideas about how this analysis can be applied to the real
world are given in Section 4.3.
4.1 Quantitative Analysis
By comparing the various metrics presented in Table 3.2, it may be possible to evaluate whether
each device’s output for a given value represents an individual’s actual sleep characteristics. Perhaps
the most concise summary of the comparability of each metric is found in Figure 3.11. The results
discussed here are summarized in Table 4.1.
Beginning with the identification of bed times in Section 3.3.1, Fitbit automatically-identified
bed times matched with Actiwatch automatically-identified bed times with a relatively high cor-
respondence of ρ = 0.821. On average, the Fitbit platform tended to estimate a bed time a few
minutes earlier than the Actiwatch. The results from the Kruskal-Wallis and Kolmogorov-Smirnov
tests, p (KW) = 0.644 and p (KS) = 0.991, provide high confidence in the similarity of bed times
reported by either platform.
Although only the Respironics platform explicity reported a wake up time, the Fitbit wake up
time could be taken as the last minute in a sleep bout time-series dataset. A very high correspondence
of ρ = 0.977 was found. On the whole, the Fitbit platform tended to estimate earlier wake up times
of just a few minutes. The ANOVA tests resulted in p (KW) = 0.817 and p (KS) = 0.991, which
provides very high confidence in the similarity of wake up times identified by both devices.
Section 3.3.2 compared three duration metrics from the Fitbit platform to five duration metrics
from the Respironics platform. Time in bed, a metric provided by both platforms, had a very high
correspondence of ρ = 0.983. The ANOVA test results were similarly high, with p (KW) = 0.908 and
p (KS) = 0.991. However, a relatively high standard deviation of σx = 16.4 minutes was observed.
These results lead to a very high confidence that time spent in bed is reported similarly between the
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platforms.
Time asleep had a similarly high correlation coefficient of ρ = 0.975. The ANOVA tests resulted
in p (KW) = 0.488 and p (KS) = 0.786. A standard deviation of σx = 17.2 minutes was observed.
These results lead to a high confidence that time asleep is reported similarly between Fitbit and
Respironics.
Although only the Respironics platform reported a metric for total sleep time (TST), it was
compared to the Fitbit reported value for time spent asleep. Slightly higher correlation and standard
deviation values resulted: ρ = 0.977, σx = 15.7 minutes. The Kruskal-Wallis and Kolmogorov-
Smirnov ANOVA tests resulted in similar values of p (KW) = 0.436 and p (KS) = 0.786. Thus,
there is high confidence that the Fitbit sleep time metric compares well to both the Actiwatch
reported TST value and the Actiwatch reported time asleep value.
Time spent awake in bed only had a reasonable correspondence of ρ = 0.710, with the ANOVA
tests resulting in p (KW) = 0.002 and p (KS) = 0.005. Thus, there is low confidence the minutes
awake compares similarly between the platforms.
Percent of time asleep was only provided by the Respironics platform, but it was considered
that this data could be calculated for Fitbit. Both calculations ended with low confidence in the
similarity of data. For calculation 1, the results were ρ = 0.751, p (KW) = 0.001, p (KS) = 0.005.
For calculation 2, the results were ρ = 0.783, p (KW) = 0.024, p (KS) = 0.066.
Similarly, percent of time awake was calculated for Fitbit. There was low confidence in the
results. For calculation 1, the results were ρ = 0.751, p (KW) = 0.001, p (KS) = 0.005. For
calculation 2, the results were ρ = 0.740, p (KW) = 0.001, p (KS) = 0.005.
Section 3.3.3 compared the number of awakenings reported by each platform. On average, the
default Fitbit platform metric reported 26 fewer awakenings than Respironics, despite a correlation
coefficient of ρ = 0.747. The ANOVA tests resulted in p (KW) = 0.000 and p (KS) = 0.000. Thus,
there is low confidence that the number of awakenings reported by each platform compare similarly.
Because the Fitbit platform reported a separate metric, number of times restless, it was consid-
ered that adding the number of times restless to the number of awakenings for each night would
improve the platform comparison. Despite an increase in the reported awakenings by Fitbit to 13.5
fewer per night than Respironoics, the correlation coefficient dropped to ρ = 0.715. ANOVA test
results were not favorable: p (KW) = 0.001 and p (KS) = 0.005. Thus, there is low confidence in
the number of awakenings comparison even with the alternate method.
Section 3.3.4 compared the wake after sleep onset (WASO) value reported by the Respironics
software to a time-series computed value on the Fitbit platform. A high correspondence of ρ = 0.919
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was found, although the Fitbit results tended to underestimate the Respironics values by 16 minutes.
The ANOVA test results were only marginal: p (KW) = 0.046 and p (KS) = 0.186. Thus, WASO
could be used in some analyses, but with extreme caution due to a medium confidence between the
platforms.
In Section 3.3.5, the sleep efficiency (SE) values reported by both platforms were compared.
It should be noted that even the two Respironics devices reported slightly less consistent values for
this metric than others (ρ = 0.943). The value reported by Fitbit corresponded with ρ = 0.778
and ANOVA values of p (KW) = 0.001 and p (KS) = 0.001. Thus, there is low confidence in the
similarity of efficiency results reported by either platform.
Sleep efficiency was calculated for Fitbit using an alternate method consistent with the metric
definition, with slightly improved results: ρ = 0.866, p (KW) = 0.002, p (KS) = 0.005. This was
not enough to change the low confidence in sleep efficiency comparisons.
Section 3.3.6 compared the sleep onset latency (SOL) metric. Only the Respironics platform
provided a native value, but it was thought that the high activity periods at the beginning of a sleep
bout could count as WASO for Fitbit. The result: ρ = 0.196, p (KW) = 0.015, p (KS) = 0.066.
Thus, there is low confidence in the similarity of sleep onset latency values for each platform.
Section 3.3.7 compared the minute-by-minute time-series output from each platform, after
scaling the data for the Respironics platform. While the histograms in Figures 3.9 and 3.10 show
a similar distribution, only a fair correspondence of ρ = 0.483 was found. The ANOVA tests resulted
in p (KW) = 0.158, p (KS) = 0.999. Thus, there is only a fair correspondence between the platforms
in terms of time-series output.
4.2 Subjective Interpretation
Some metrics compare favorably between the two platforms, including bed time, wake up time,
time in bed, time asleep, and total sleep time (TST). The time-series and wake after sleep onset
(glswaso) may be used to infer sleep diagnostics, albeit with knowledge of the specific limitations of
each metric.
Other metrics, including time awake, number of awakenings, sleep efficiency (SE), sleep onset
latency (SOL), percent of time asleep, and percent of time awake do not compare favorably between
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Table 4.1: Results of Metric Comparisons
Metric Confidence Remarks
Bed time High Fitbit estimates slightly
earlier
Wake up time Very high Fitbit estimates slightly
earlier
Time spent in bed Very high Somewhat high standard
deviation
Time spent asleep High Somewhat high standard
deviation
Total sleep time (TST) High -
Time spent awake Low -
Number of awakenings Low -
(reported)
Number of awakenings Low -
(Fitbit calculated)
Wake after sleep onset Medium Fitbit tends to underestimate
(WASO) Actiwatch
Sleep efficiency (SE) Low -
(reported)
Sleep efficiency (SE) Low -
(Fitbit calculated)
Sleep onset latency (SOL) Low -
% of time asleep Low -
(reported)
% of time asleep Low -
(Fitbit calculated)
% of time awake Low -
(reported)
% of time awake Low -
(Fitbit calculated)
Time-series Medium -
the platforms. Until further testing can prove or disprove the validity of the results from either
platform, one should not attempt to infer sleep information from these metrics.
However, because the medical-grade Actiwatch has been approved for clinical use, it is likely that
its results are more reflective of reality than Fitbit. Following this logic, the Fitbit bed time, wake
up time, time spent in bed, time spent asleep, and total sleep time (glstst) are likely reflective of the
individual’s actual sleep schedule. Likewise, this logic means that the low-confidence metrics of time
awake, number of awakenings, sleep efficiency (SE), sleep onset latency (SOL), and the percentages
are absolutely not reflective of reality.
While the observer should look at the Fitbit time-series data with careful skepticism, certain
insights can still be gained. For example, Figures 3.3-3.8 show that a number of medium- and
high-activity events appear on both devices.
In addition, while most of the quality metrics did not compare favorably, sleep quality can be
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determined in other ways. For example, healthy individuals generally have a sleep period that is
similar in length, start, and end time each night. If a series of nights are tracked, it may be possible
to infer changes in sleep quality just by looking at the duration, start, and end time of a sleep event.
While the consumer-grade device metrics cannot necessarily be used to diagnose sleep conditions,
individuals can benefit from a deeper understanding of their sleep hygiene. When these data points
are presented directly to the end user, he or she may be able to generate individual insights about
recent changes in habits and diet. This awareness may be the first important step in improving the
sleep health of millions of people.
In addition, these data points likely contain more than enough data for new technologies, such
as circadian-adaptive lighting and drug delivery systems, to intelligently respond to individuals’
circadian needs.
4.3 Actigraphy in the Real World
Avi Sadeh, in a 2011 clinical review, reported that actigraphy (ACT) can provide reasonably good
insights for individuals with average to good sleep quality, but validity in special populations is
questionable. The primary issue is the difficulty of the devices to accurately detect wake periods
during sleep in these special populations [18]. Put another way, sleep schedule parameters are
classified relatively well, but sleep quality parameters do not match subjective data as closely. ACT
is typically indicated in parallel with sleep logs and questionnaires to infer subjective quality [32].
Similarly, the metrics which aligned most closely between the Fitbit and Respironics platforms
were mostly related to schedule: bed time, wake up time, time spent in bed, time spent asleep,
and total sleep time (TST). The parameters more closely linked to quality all resulted in lower
correspondence or had statistically significant differences in the results: efficiency (SE), number of
awakenings, sleep onset latency (SOL), wake after sleep onset (WASO) and percent of time asleep
and awake.
As Sadeh and others have pointed out, it is recommended that ACT is used in conjunction with
subjective sleep evaluation metrics, especially in individuals with abnormal sleep hygiene. Unless a
breakthrough in sensor technology is reached, applications built around consumer tracking devices
should take subjective information into account if quality is to be inferred. Otherwise, people may
be mislead by certain data. Indeed, Sleep as Android, a smartphone-based ACT application that
uses the accelerometer in the phone, asks users to rate their sleep along with a display of the metrics
from the most recent sleep bout [43]. Other applications may consider alternate ways of taking
52
subjective sleep quality ratings into account.
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Chapter 5: Conclusion
At first glance, it is difficult to comprehend the difference of 1-2 orders of magnitude in price between
consumer and medical-grade actigraphy (ACT) devices. They are similar electronically, and the
consumer devices offer attractive features the more-expensive alternatives do not. However, the
medical-grade device output is approved by various regulatory bodies, and individuals who evaluate
the results are typically highly qualified. While the cheaper device is not subject to such stringent
regulation, it may be difficult to determine how much the data output reflects reality.
While this project cannot determine how well the results from either device type reflect the true
sleep situation (e.g. by using polysomnography (PSG) in conjunction with the test devices), it has
been an attempt to compare the results from examples of common medical- and consumer-grade
ACT products. It is possible that the consumer device does a better job of estimating specific
metrics than its medical counterpart in comparison to PSG, but that is work for a separate project.
What can be determined is how well the various metrics correspond between the devices. This
is summarized succinctly in Table 4.1 and expanded on in Chapters 3 and 4. Measures related
to schedule correspond most closely, while quality measures do not correlate as well between the
platforms. This seems to reflect the state of ACT devices in the real world, as reported by Sadeh
and others [16, 18].
It can be concluded that fitness trackers are decent indicators of sleep health, and they may be
used to gain a subjective impression of temporal hygiene. However, this data should be used in
conjunction with subjective measures, and should not be used to diagnose sleep conditions.
The result that the consumer-grade trackers’ data compare well to the clinical alternatives on
multiple metrics opens the door for quite a few possibilities in the realm of personalized medicine.
In the following paragraphs, examples are provided of how to use the results of this analysis for the
three case studies presented in Section 2.4.
The first use case is intelligent environments that adapt intelligently to individuals’ circadian
needs. Because the system knows the user’s exact bed time, wake up time, time spent in bed, and
time spent asleep/total sleep time (TST), it can track consistency and length of sleep episodes over
time. If the ratio of TST or time spent asleep to time in bed shrinks, the system will know in
short order that the most recent sleep episode was compromised. It can then increase circadian
stimulation in the morning (e.g. brighter lights, higher temperatures) to promote alertness. The
following evening, the lights can be dimmer than normal (and the temperature cooler) to coax
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the user into sleep. In this way, an adaptive environment can help normalize sleep hygiene in an
unobtrusive way.
The second scenario is circadian-adaptive drug delivery. Because the system has tracked the
sleep time measures, it can determine if a change in administration or dose has any effect on sleep.
In addition, while the Fitbit time-series amplitude data only has medium correspondence to the
Actiwatch output, peaks of activity can be distinguished from the baseline. The use of daytime
time-series amplitude data and time-series heart rate output, neither of which were tested in this
experiment, could help the system identify an individual’s peaks and troughs of activity. These
activity levels may correspond with energy levels and bioavailability of specific medications, but
more work must be done to understand if any links exist in this area.
The final example is individualized health recommendations. Based on the sleep time indicators,
the system could determine an individual’s chronotype (e.g. early bird, night owl) and suggest
activities that provide or prevent circadian stimulation based on those chronotypes. For example,
the software might recommend exercise and early morning sun exposure to prevent sluggishness in
night owls. It might recommend that early birds minimize light exposure and high levels of activity
in the evening to promote sleep. Changes in habit or diet may show up in sleep time results, and
potentially even in time-series data. Again, more work must be done to get to this point, but the
groundwork has been established in this thesis.
In addition to the three scenarios, there are additional possibilities for consumer activity track-
ers. Informal sleep studies may take place to give researchers or employers a general picture of a
population’s sleep status outside of a more formal (and more expensive) experiment. Individuals can
perform N of 1 experiments (where there is only a single subject) on themselves and evaluate how
different habits and dietary alterations affect sleep, trusting that the results are reasonably realistic.
Multiple smartwatches are being released with ACT features and components built in. As wear-
able technology becomes ubiquitous, it is possible that billions of people will already own the hard-
ware that enables circadian tracking within a few short years. Enabling this hardware for deep
circadian analysis may be as simple as downloading an app.
In today’s increasingly-connected world, the need for healthy, stable circadian rhythms is more
important than ever. It is possible that recent and upcoming technologies may enable, rather than
hinder, better sleep in the world of tomorrow.
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Subject ID: 0002 
DOB: 1/1/1994                           Age: 21                       Gender: Male 
Recording Period: from 8/5/2015 7:28:00 AM to 8/19/2015 7:27:00 AM 
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Min 
11:13:00 PM 6:31:00 AM 5:37:00 4:38:00 0.00 79.20 26.00 16 
        
Max 
2:55:00 AM 10:21:00 AM 9:51:00 8:42:00 13.00 92.62 72.00 38 
        
Avg 
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Daily Statistics: 













        Tuesday 
8/4/2015 
NaN NaN NaN NaN NaN NaN NaN NaN 
        
Wednesday 
8/5/2015 
2:06:00 AM 7:43:00 AM 5:37:00 4:45:00 13.00 84.57 30.00 16 
        Thursday 
8/6/2015 
2:55:00 AM 9:37:00 AM 6:42:00 5:57:00 0.00 88.81 33.00 21 
        Friday 
8/7/2015 
12:00:00 AM 9:04:00 AM 9:04:00 8:06:00 0.00 89.34 57.00 38 
        Saturday 
8/8/2015 
12:40:00 AM 6:31:00 AM 5:51:00 4:38:00 6.00 79.20 61.00 28 
        Sunday 
8/9/2015 
11:27:00 PM 7:57:00 AM 8:30:00 7:14:00 0.00 85.10 72.00 38 
        Monday 
8/10/2015 
11:13:00 PM 7:01:00 AM 7:48:00 6:38:00 2.00 85.04 67.00 36 
        Tuesday 
8/11/2015 
11:17:00 PM 7:19:00 AM 8:02:00 6:36:00 0.00 82.16 61.00 34 
        
Wednesday 
8/12/2015 
12:17:00 AM 8:52:00 AM 8:35:00 7:57:00 0.00 92.62 37.00 20 
        Thursday 
8/13/2015 
11:41:00 PM 9:19:00 AM 9:38:00 8:42:00 5.00 90.31 50.00 30 
        Friday 
8/14/2015 
1:42:00 AM 8:14:00 AM 6:32:00 6:01:00 0.00 92.09 26.00 20 
        Saturday 
8/15/2015 
12:30:00 AM 10:21:00 AM 9:51:00 8:35:00 4.00 87.14 57.00 37 
        Sunday 
8/16/2015 
11:57:00 PM 8:39:00 AM 8:42:00 7:41:00 0.00 88.31 52.00 29 
        Monday 
8/17/2015 
12:48:00 AM 8:15:00 AM 7:27:00 6:30:00 0.00 87.25 42.00 28 
        Tuesday 
8/18/2015 
NaN NaN NaN NaN NaN NaN NaN NaN 
Each day represented above is from 12:00:00 PM to 12:00:00 PM on the next day. 
 
Summary Statistics: 













        
Min 
11:13:00 PM 6:31:00 AM 5:37:00 4:38:00 0.00 79.20 26.00 16 
        
Max 
2:55:00 AM 10:21:00 AM 9:51:00 8:42:00 13.00 92.62 72.00 38 
        
Avg 
12:30:13 AM 8:22:27 AM 7:52:13 6:52:18 2.31 87.07 49.62 28.85 
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